Loading…
Transforming outcomes in alcohol-associated liver disease through integrated, patient-centered care.
Office bearers
Prof. Sanjaya Satapathy
Chair
MD · Liver Transplant
Why this SIG, right now
Alcohol-associated liver disease is rising at an alarming rate, particularly among younger populations, and is now a leading indication for liver transplantation in many regions.
Three key forces define this moment:
ALD-related hospitalizations and mortality have increased significantly over the past decade, accelerated further by the COVID-19 pandemic.
Effective management of ALD requires treating the underlying alcohol use disorder.
Early liver transplantation for severe alcohol-associated hepatitis is no longer experimental—it is an accepted, evidence-based option in carefully selected patients.
Join Alcohol-Associated Liver Disease (ALD) to read and participate in the discussion board.
Sign In